PLoS Comput Biol:科研合作十条简明规则

2015-07-16 刘立博客 科学网博客园

在我国,科研合作是一个“老大难”问题。科技界有所谓“四同”说法,即申请课题时同心协力;做课题时同床异梦;荣誉分配时同室操戈;最后落个同归于尽。 Vicens和Bourne(2007)发表的“科研合作十条简明规则”,对避免科研合作的失败具有指导意义。现编译如下: 规则1:不要神马合作都参加,要有取舍。是否参加某个合作项目,要充分考虑自己的科研兴趣、专长和时间。如果不合这些,那么即使合作项目再有诱

在我国,科研合作是一个“老大难”问题。科技界有所谓“四同”说法,即申请课题时同心协力;做课题时同床异梦;荣誉分配时同室操戈;最后落个同归于尽。

Vicens和Bourne(2007)发表的“科研合作十条简明规则”,对避免科研合作的失败具有指导意义。现编译如下:

规则1:不要神马合作都参加,要有取舍。是否参加某个合作项目,要充分考虑自己的科研兴趣、专长和时间。如果不合这些,那么即使合作项目再有诱惑性,也应当婉言谢绝。如果不想参加合作项目,那么你应当尽早说“不”,快刀斩乱麻。

规则2:科研合作要有明确的分工。项目一开始,就应对合作者各自承担的任务进行明确的分工。项目进行中,分工可能有调整,应向课题负责人和合作者及时通报。

规则3:不要偏离当初商定的任务目标。在课题进行中即使你产生了新的思路,也不要改变原来设定的项目计划。不要节外生枝,不要打乱合作项目的整体计划。

规则4:要抱有开放诚实的态度。数据资料尽可能与合作者共享;Paper发表之前应该让合作者知晓,并恰当考虑署名的顺序。在合作中不要心里打小算盘,搞小九九。

规则5:要相互理解、宽容和尊重。合作者的能力、兴趣、投入时间、性格等各不相同,要努力做到和而不同。

规则6:合作者之间要经常沟通。沟通的方式多种多样,比如邮件、电话、SKYPE等。如有机会,尽可能进行面对面沟通。

规则7:如果某合作者有拖延症,拖了整个合作项目的后退,并伤害了你的情绪。你可以给他/她3次弥补的机会,如果仍无起色,那么就换人。

规则8:要对合作者心存感谢,并给他/她适当的名份,尤其是要体现在Paper署名中。

规则9:当你在科研合作中遇到严重的挑战和危机时,不要轻言放弃,一走了之。此时你要虚心向有经验的科学家寻求帮助和建议,或许会让你感到柳暗花明又一春。

规则10:成功的愉快的合作,要保持下去。如果合作失败,很受伤,那就分道扬镳,你走你的阳关道,我走我的独木桥。

原始出处

Vicens Q, Bourne PE.Ten simple rules for a successful collaboration.PLoS Comput Biol. 2007 Mar 30

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2016455, encodeId=7ca42016455e8, content=<a href='/topic/show?id=7070e5009be' target=_blank style='color:#2F92EE;'>#科研合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75009, encryptionId=7070e5009be, topicName=科研合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Wed Sep 09 19:35:00 CST 2015, time=2015-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766950, encodeId=5d231e669501c, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Mon Jul 27 01:35:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917171, encodeId=2a3c191e17149, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Feb 05 18:35:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32920, encodeId=1d1c32920c1, content=不错。, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Jul 16 18:12:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32894, encodeId=cdc2328944a, content=非常不错,这些经验值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Thu Jul 16 17:00:00 CST 2015, time=2015-07-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2016455, encodeId=7ca42016455e8, content=<a href='/topic/show?id=7070e5009be' target=_blank style='color:#2F92EE;'>#科研合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75009, encryptionId=7070e5009be, topicName=科研合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Wed Sep 09 19:35:00 CST 2015, time=2015-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766950, encodeId=5d231e669501c, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Mon Jul 27 01:35:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917171, encodeId=2a3c191e17149, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Feb 05 18:35:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32920, encodeId=1d1c32920c1, content=不错。, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Jul 16 18:12:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32894, encodeId=cdc2328944a, content=非常不错,这些经验值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Thu Jul 16 17:00:00 CST 2015, time=2015-07-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2016455, encodeId=7ca42016455e8, content=<a href='/topic/show?id=7070e5009be' target=_blank style='color:#2F92EE;'>#科研合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75009, encryptionId=7070e5009be, topicName=科研合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Wed Sep 09 19:35:00 CST 2015, time=2015-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766950, encodeId=5d231e669501c, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Mon Jul 27 01:35:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917171, encodeId=2a3c191e17149, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Feb 05 18:35:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32920, encodeId=1d1c32920c1, content=不错。, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Jul 16 18:12:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32894, encodeId=cdc2328944a, content=非常不错,这些经验值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Thu Jul 16 17:00:00 CST 2015, time=2015-07-16, status=1, ipAttribution=)]
    2016-02-05 sunylz
  4. [GetPortalCommentsPageByObjectIdResponse(id=2016455, encodeId=7ca42016455e8, content=<a href='/topic/show?id=7070e5009be' target=_blank style='color:#2F92EE;'>#科研合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75009, encryptionId=7070e5009be, topicName=科研合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Wed Sep 09 19:35:00 CST 2015, time=2015-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766950, encodeId=5d231e669501c, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Mon Jul 27 01:35:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917171, encodeId=2a3c191e17149, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Feb 05 18:35:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32920, encodeId=1d1c32920c1, content=不错。, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Jul 16 18:12:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32894, encodeId=cdc2328944a, content=非常不错,这些经验值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Thu Jul 16 17:00:00 CST 2015, time=2015-07-16, status=1, ipAttribution=)]
    2015-07-16 ndd99

    不错。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2016455, encodeId=7ca42016455e8, content=<a href='/topic/show?id=7070e5009be' target=_blank style='color:#2F92EE;'>#科研合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75009, encryptionId=7070e5009be, topicName=科研合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Wed Sep 09 19:35:00 CST 2015, time=2015-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766950, encodeId=5d231e669501c, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Mon Jul 27 01:35:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917171, encodeId=2a3c191e17149, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Feb 05 18:35:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32920, encodeId=1d1c32920c1, content=不错。, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Jul 16 18:12:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32894, encodeId=cdc2328944a, content=非常不错,这些经验值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Thu Jul 16 17:00:00 CST 2015, time=2015-07-16, status=1, ipAttribution=)]
    2015-07-16 medcardio

    非常不错,这些经验值得学习

    0

相关资讯

科研思维与论文写作之“5C”法则

科学研究是开拓求新和严谨求实的有机结合,在科研设计和论文撰写的过程中需要遵循一些基本原则。本文创新性地提出科研思维和论文写作的“5C”法则,包括评判性(critical)、一致性(consistent)、简洁性(concise)、清晰性(clear)和完整性(complete),以期为年轻学者的科研训练和研究生教育提供参考。 科学研究实践可以用胡适先生提出的“大胆假设,小心求证”进行

王善勇:科研的品位与执行力

说到科研的品位,更多时候我觉着应该是对导师的要求。那么什么是科研的品位呢?科研的品位还有高低之分吗?咱们先试着回答第一个问题。一个人在科研上的品位,并不是指这个人表面上拥有多高的地位,掌握多少资源,承担了多少高大上的项目,而是指一个人洞察科学问题的敏锐度,前瞻性与预见性的能力。现在这个时代搞科研,学科已经分得不能再细,远不是牛顿,爱因斯坦那个年代,那种划时代的理论或技术,革命性的原创已经非常艰难,

读《学术思想枯竭》联想

阅读肖建华老师文章《学术思想枯竭》,很有启发。先整理一下阅读体会。肖老师是从不同类型学术期刊的角度分析,一类是基础理论类,另一类是应用类。往更大范围说,这也对应于科学和技术。无论是那类学者和期刊,真正能提出创新学术思想的人很少。但相对来说,基础理论是创新的主要源头,但新理论往往无法被老范式的垄断学者接受,新思想开始往往不够完善,搞理论的觉得太粗燥,搞应用的觉得太空虚,一般是上不靠天,下不立地没有市

这些经验帮你科研少走弯路

这实在是一篇少走许多学习弯路的好文章,大家可以好好吸取一下前人的经验。 1. 先看综述,后看论著。看综述搞清概念,看论著掌握方法。 2. 早动手在师兄师姐离开之前学会关键技术。 3. 多数文章看摘要,少数文章看全文。掌握了一点查全文的技巧,往往会以搞到全文为乐,以至于没有时间看文章的内容,更不屑于看摘要。真正有用的全文并不多,过分追求全文是浪费,不可走极端。当然只看摘要也是不对的。

科研需要兴趣和自信

科研是甘坐的冷板凳的高冷兴趣。我把它归结为兴趣而不是职业是因为把科研当职业干会变得累、浮躁、势利,甚至弄虚作假。一旦走到弄虚作假的地步就与社会上的坑蒙拐骗没有什么两样,只不过科研上的“坑蒙拐骗”显得更高大上,就因为这种高大上其危害的隐蔽性、长期性和短暂“成功”后的喜悦感会让一个人彻底迷失方向。科研是兴趣。这就是我为什么自己坚持从事自然地理的原因。我在考研的时候是考的是人文地理专业的硕士生,因为没有

科研5.0

一、21世纪科研创新特点科学研究的定义是:为了增进知识,以及利用这些知识去发明新的技术而进行的系统的创造性工作。科研活动发展到当今的阶段,早已不是大众想象中的 “爱迪生试用了接近1600种灯丝材料最终成功发明了电灯泡”这样的模式了。“科研”成为了多个职业科研人员进行的高度分工又高度合作的一项工作。 具体到医学方向,我们可以看到以下几个方面的特点:1)研究深度:由整体向细胞水平、分子水平,又向系